Susquehanna International Group
SRPT icon

Susquehanna International Group’s Sarepta Therapeutics SRPT Stock Holding History

Susquehanna International Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.5M Buy
897,532
+469,923
+110% +$9.1M ﹤0.01% 2253
2025
Q4 		$9.2M Sell
427,609
-563,257
-57% -$11.9M ﹤0.01% 3153
2025
Q3 		$19.1M Buy
990,866
+810,620
+450% +$14.5M ﹤0.01% 2254
2025
Q2 		$3.08M Buy
180,246
+121,470
+207% +$5.18M ﹤0.01% 4910
2025
Q1 		$3.75M Sell
58,776
-9,127
-13% -$961K ﹤0.01% 4209
2024
Q4 		$8.26M Sell
67,903
-42,272
-38% -$5.18M ﹤0.01% 2895
2024
Q3 		$13.8M Sell
110,175
-84,619
-43% -$11.7M ﹤0.01% 2216
2024
Q2 		$30.8M Sell
194,794
-86,903
-31% -$11.2M 0.01% 1334
2024
Q1 		$36.5M Buy
281,697
+156,096
+124% +$19.1M 0.01% 1251
2023
Q4 		$12.1M Sell
125,601
-14,740
-11% -$1.41M ﹤0.01% 2393
2023
Q3 		$17M Sell
140,341
-95,020
-40% -$10.7M ﹤0.01% 1919
2023
Q2 		$27M Buy
235,361
+95,534
+68% +$12.3M 0.01% 1454
2023
Q1 		$19.3M Buy
139,827
+31,880
+30% +$4.14M ﹤0.01% 1750
2022
Q4 		$14M Buy
107,947
+52,331
+94% +$6.06M ﹤0.01% 1863
2022
Q3 		$6.15M Buy
55,616
+52,824
+1,892% +$5.32M ﹤0.01% 2849
2022
Q2 		$209K Sell
2,792
-13,966
-83% -$1.03M ﹤0.01% 10527
2022
Q1 		$1.31M Sell
16,758
-321,659
-95% -$24.6M ﹤0.01% 6462
2021
Q4 		$30.5M Buy
338,417
+1,698
+0.5% +$145K ﹤0.01% 1456
2021
Q3 		$31.1M Buy
336,719
+136,888
+69% +$10.5M ﹤0.01% 1560
2021
Q2 		$15.5M Sell
199,831
-41,689
-17% -$3.16M ﹤0.01% 2333
2021
Q1 		$18M Buy
241,520
+97,927
+68% +$9.04M ﹤0.01% 1997
2020
Q4 		$24.5M Buy
143,593
+70,462
+96% +$10.4M ﹤0.01% 1528
2020
Q3 		$10.3M Buy
73,131
+44,255
+153% +$6.73M ﹤0.01% 2139
2020
Q2 		$4.63M Sell
28,876
-64,219
-69% -$8.74M ﹤0.01% 3106
2020
Q1 		$9.11M Sell
93,095
-85,834
-48% -$9.81M ﹤0.01% 1832
2019
Q4 		$23.1M Sell
178,929
-379,710
-68% -$38.3M 0.01% 1289
2019
Q3 		$42.1M Buy
558,639
+200,313
+56% +$23.7M 0.01% 839
2019
Q2 		$54.4M Buy
358,326
+128,316
+56% +$15.6M 0.02% 647
2019
Q1 		$27.4M Sell
230,010
-102,667
-31% -$13.2M 0.01% 976
2018
Q4 		$36.3M Sell
332,677
-140,983
-30% -$17.6M 0.01% 723
2018
Q3 		$76.5M Sell
473,660
-463,422
-49% -$63.4M 0.03% 526
2018
Q2 		$124M Buy
937,082
+630,493
+206% +$59.5M 0.04% 351
2018
Q1 		$22.7M Sell
306,589
-868,215
-74% -$57.9M 0.01% 1125
2017
Q4 		$65.4M Buy
1,174,804
+169,159
+17% +$8.96M 0.02% 580
2017
Q3 		$45.6M Buy
1,005,645
+166,894
+20% +$6.67M 0.02% 681
2017
Q2 		$28.3M Buy
838,751
+571,072
+213% +$18.6M 0.01% 908
2017
Q1 		$7.92M Sell
267,679
-458,365
-63% -$14.2M ﹤0.01% 1860
2016
Q4 		$19.9M Buy
726,044
+695,658
+2,289% +$27.9M 0.01% 1054
2016
Q3 		$1.87M Sell
30,386
-519,576
-94% -$15.7M ﹤0.01% 3682
2016
Q2 		$10.5M Sell
549,962
-27,085
-5% -$502K 0.01% 1419
2016
Q1 		$11.3M Sell
577,047
-109,719
-16% -$1.92M 0.01% 1445
2015
Q4 		$26.5M Buy
686,766
+37,370
+6% +$1.21M 0.01% 941
2015
Q3 		$20.9M Buy
649,396
+48,400
+8% +$1.64M 0.01% 1165
2015
Q2 		$18.3M Buy
600,996
+129,347
+27% +$2.64M 0.01% 1385
2015
Q1 		$6.26M Sell
471,649
-11,702
-2% -$156K ﹤0.01% 2428
2014
Q4 		$6.99M Buy
483,351
+66,558
+16% +$1.13M ﹤0.01% 2420
2014
Q3 		$8.79M Buy
416,793
+366,991
+737% +$8.28M ﹤0.01% 2257
2014
Q2 		$1.48M Sell
49,802
-384,993
-89% -$12.2M ﹤0.01% 5249
2014
Q1 		$10.4M Buy
434,795
+18,449
+4% +$470K ﹤0.01% 1965
2013
Q4 		$8.48M Buy
416,346
+385,546
+1,252% +$11.5M ﹤0.01% 2255
2013
Q3 		$1.45M Sell
30,800
-559,177
-95% -$21.5M ﹤0.01% 4656
2013
Q2 		$22.4M Buy
+589,977
New +$21.1M 0.01% 1029

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's SRPT Position: Q1 2026 in Review

Susquehanna International Group increased its Sarepta Therapeutics (SRPT) stake by 110% in Q1 2026, buying an estimated $9.1M and bringing the position to 897,532 shares worth $19.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Susquehanna International Group first reported a position in SRPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $124M in Q2 2018. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Susquehanna International Group held 897,532 shares of Sarepta Therapeutics worth $19.5M as of Q1 2026.
  • Susquehanna International Group bought 469,923 Sarepta Therapeutics shares in Q1 2026, an estimated $9.1M.
  • Sarepta Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2253 holding.
  • Susquehanna International Group first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Susquehanna International Group's Sarepta Therapeutics position peaked at $124M in Q2 2018.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.